Results 291 to 300 of about 2,501,512 (375)
Editorial: Community series in autoantibodies, volume II. [PDF]
Kyriakou A, Patsatsi A.
europepmc +1 more source
ABSTRACT Background There is no consensus on how best to assess the impact of living with mycosis fungoides (MF)/Sézary syndrome (SS) on a patient's quality of life. Objectives To identify all potential concepts that describe disease severity or contribute to health‐related quality of life (HRQOL) from patients with MF/SS and their care partners ...
Christina Asare+13 more
wiley +1 more source
Genital Psoriasis: Shining Light on This Hidden Disease
Psoriasis occurring on skin of the genital and perigenital regions has specific diagnostic and treatment requirements due to the sensitivity and private nature of these areas. A multidisciplinary group of experts in the management of genital psoriasis, the Genital Psoriasis Wellness Consortium, convened to discuss the impact of genital psoriasis on ...
Jennifer Cather+19 more
wiley +1 more source
A 10-Year Observational Study on Treatment Approaches in Pemphigus and Pemphigoid. [PDF]
Pereira CP+6 more
europepmc +1 more source
ABSTRACT Background Patients with dermatological immune mediated inflammatory diseases (IMIDs) are increasingly treated with immunosuppressive and ‐modulating drugs. Some of these drugs increase the risk of acquiring infections and more complications can arise during an infection while treated with these agents.
Femke Lieten+8 more
wiley +1 more source
Mycosis Fungoides in Paediatric Patients: A Real‐Life Retrospective Study
Our study represents the largest cohort of children with MF worldwide, providing relevant evidence supporting phototherapy as first‐line treatment, with an overall remission rate of 36.36%. Both topical and systemic therapy also showed favourable outcomes.
Mariana de la Vega+2 more
wiley +1 more source
Cutaneous Larva Migrans Refractory to Therapy with Ivermectin: Case Report and Review of Implicated Zoonotic Pathogens, Epidemiology, Anthelmintic Drug Resistance and Therapy. [PDF]
Currie BJ, Hoopes J, Cumming B.
europepmc +1 more source